ONCOSEC MEDICAL INCORPORATED: 10-Q filed 2018-06-13
What ONCOSEC MEDICAL INCORPORATED reported in its quarterly report filed 2018-06-13 (fiscal Q3 2018): 31 published measures, 79 facts as tagged in accession 0001493152-18-008598.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2018-06-13
- Fiscal period
- fiscal Q3 2018
- Accession
- 0001493152-18-008598 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ONCOSEC MEDICAL INCORPORATED filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-04-30 | 37,059,150 | USD | |
| At 2017-07-31 | 15,232,909 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-04-30 | 4,355,931 | USD | |
| At 2017-07-31 | 4,536,927 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-04-30 | 32,703,219 | USD | |
| At 2017-07-31 | 10,695,982 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-04-30 | 10,118,965 | USD | |
| At 2017-07-31 | 11,444,676 | USD | |
| At 2017-04-30 | 16,106,338 | USD | |
| At 2016-07-31 | 28,746,224 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-02-01 to 2018-04-30 | -10,060,553 | USD | 89 |
| 2017-08-01 to 2018-04-30 | -26,697,105 | USD | 273 |
| 2017-02-01 to 2017-04-30 | -4,560,972 | USD | 89 |
| 2016-08-01 to 2017-04-30 | -15,551,867 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-08-01 to 2018-04-30 | -17,000,194 | USD | 273 |
| 2016-08-01 to 2017-04-30 | -12,712,409 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-08-01 to 2018-04-30 | 51,666 | USD | 273 |
| 2016-08-01 to 2017-04-30 | 9,578 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-08-01 to 2018-04-30 | 38,968,307 | USD | 273 |
| 2016-08-01 to 2017-04-30 | 75,007 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-08-01 to 2018-04-30 | -23,285,891 | USD | 273 |
| 2016-08-01 to 2017-04-30 | -9,578 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-04-30 | -121,641,561 | USD | |
| At 2017-07-31 | -94,944,455 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-08-01 to 2018-04-30 | 951 | USD | 273 |
| 2016-08-01 to 2017-04-30 | 1,391 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-04-30 | 1,295,669 | USD | |
| At 2017-07-31 | 2,410,099 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-08-01 to 2018-04-30 | 5,904,920 | USD | 273 |
| 2016-08-01 to 2017-04-30 | 3,378,991 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-02-01 to 2018-04-30 | -9,292,170 | USD | 89 |
| 2017-08-01 to 2018-04-30 | -23,504,391 | USD | 273 |
| 2017-02-01 to 2017-04-30 | -4,671,932 | USD | 89 |
| 2016-08-01 to 2017-04-30 | -15,750,208 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-04-30 | 32,418,124 | USD | |
| At 2017-07-31 | 12,513,623 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-04-30 | 3,195,837 | USD | |
| At 2017-07-31 | 3,395,974 | USD |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-04-30 | 51,892,734 | shares | |
| At 2017-07-31 | 21,618,194 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-04-30 | -11,553 | USD | |
| At 2017-07-31 | -3,620 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-04-30 | 32,703,219 | USD | |
| At 2017-07-31 | 10,695,982 | USD | |
| At 2017-04-30 | 15,962,329 | USD | |
| At 2016-07-31 | 28,053,104 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-04-30 | 1,963,824 | USD | |
| At 2017-07-31 | 3,233,768 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-04-30 | 668,155 | USD | |
| At 2017-07-31 | 823,669 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-04-30 | 369,833 | USD | |
| At 2017-07-31 | 309,187 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-04-30 | 1,160,094 | USD | |
| At 2017-07-31 | 1,140,953 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-04-30 | 360,341 | USD | |
| At 2017-07-31 | 114,841 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-02-01 to 2018-04-30 | -10,060,553 | USD | 89 |
| 2017-08-01 to 2018-04-30 | -26,696,154 | USD | 273 |
| 2017-02-01 to 2017-04-30 | -4,560,972 | USD | 89 |
| 2016-08-01 to 2017-04-30 | -15,550,476 | USD | 273 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-02-01 to 2018-04-30 | -10,092,352 | USD | 89 |
| 2017-08-01 to 2018-04-30 | -26,705,038 | USD | 273 |
| 2017-02-01 to 2017-04-30 | -4,553,892 | USD | 89 |
| 2016-08-01 to 2017-04-30 | -15,544,773 | USD | 273 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-08-01 to 2018-04-30 | -121,600,000 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-02-01 to 2018-04-30 | 5,138,942 | USD | 89 |
| 2017-08-01 to 2018-04-30 | 12,943,077 | USD | 273 |
| 2017-02-01 to 2017-04-30 | 2,015,859 | USD | 89 |
| 2016-08-01 to 2017-04-30 | 7,111,785 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-02-01 to 2018-04-30 | 100,000 | USD | 89 |
| 2017-08-01 to 2018-04-30 | 273,136 | USD | 273 |
| 2017-02-01 to 2017-04-30 | 100,000 | USD | 89 |
| 2016-08-01 to 2017-04-30 | 284,319 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-02-01 to 2018-04-30 | 91,217 | USD | 89 |
| 2017-08-01 to 2018-04-30 | 148,731 | USD | 273 |
| 2017-02-01 to 2017-04-30 | 110,960 | USD | 89 |
| 2016-08-01 to 2017-04-30 | 199,732 | USD | 273 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-08-01 to 2018-04-30 | 951 | USD | 273 |
| 2016-08-01 to 2017-04-30 | 1,391 | USD | 273 |
Inspect the source
- Entity
- ONCOSEC MEDICAL INCORPORATED / CIK 0001444307
- Captured
- SEC response SHA-256
326bcab6a98b5e6098a865fe967c999ac8b3247d9466d112c5306da6df2f5607
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001444307.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))